272 related articles for article (PubMed ID: 1351305)
1. Measurement of depression and negative symptoms in schizophrenia.
Goldman RS; Tandon R; Liberzon I; Greden JF
Psychopathology; 1992; 25(1):49-56. PubMed ID: 1351305
[TBL] [Abstract][Full Text] [Related]
2. Measurement of mood and affect in schizophrenic inpatients.
Craig TJ; Richardson MA; Pass R; Bregman Z
Am J Psychiatry; 1985 Nov; 142(11):1272-7. PubMed ID: 4061685
[TBL] [Abstract][Full Text] [Related]
3. [Antidepressive effect of pyridoxine (vitamin B6) in neuroleptic-treated schizophrenic patients with co-morbid minor depression--preliminary open-label trial].
Shiloh R; Weizman A; Weizer N; Dorfman-Etrog P; Munitz H
Harefuah; 2001 May; 140(5):369-73, 456. PubMed ID: 11419053
[TBL] [Abstract][Full Text] [Related]
4. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.
Mauri MC; Moliterno D; Rossattini M; Colasanti A
Schizophr Res; 2008 Feb; 99(1-3):7-12. PubMed ID: 18055177
[TBL] [Abstract][Full Text] [Related]
5. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia.
Newcomer JW; Faustman WO; Yeh W; Csernansky JG
Psychiatry Res; 1990 Mar; 31(3):243-50. PubMed ID: 2333356
[TBL] [Abstract][Full Text] [Related]
7. Thioridazine improves affective symptoms in schizophrenic patients.
Dufresne RL; Valentino D; Kass DJ
Psychopharmacol Bull; 1993; 29(2):249-55. PubMed ID: 8290673
[TBL] [Abstract][Full Text] [Related]
8. [A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS].
Loas G; Noisette C; Legrand A; Delahousse J
Encephale; 1997; 23(1):10-8. PubMed ID: 9172962
[TBL] [Abstract][Full Text] [Related]
9. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
[TBL] [Abstract][Full Text] [Related]
10. A comparison of instrument sensitivity to negative symptom change.
Eckert SL; Diamond PM; Miller AL; Velligan DI; Funderburg LG; True JE
Psychiatry Res; 1996 Jun; 63(1):67-75. PubMed ID: 8832775
[TBL] [Abstract][Full Text] [Related]
11. Treatment of depressive symptoms in patients with schizophrenia: a randomized, open-label, parallel-group, flexible-dose subgroup analysis of patients treated with extended-release quetiapine fumarate or risperidone.
Kasper S; Montagnani G; Trespi G; Di Fiorino M
Int Clin Psychopharmacol; 2015 Jan; 30(1):14-22. PubMed ID: 25356632
[TBL] [Abstract][Full Text] [Related]
12. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.
El Yazaji M; Battas O; Agoub M; Moussaoui D; Gutknecht C; Dalery J; d'Amato T; Saoud M
Schizophr Res; 2002 Jul; 56(1-2):121-7. PubMed ID: 12084426
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].
Langlois-Thery S; Dollfus S; Lesieur P; Petit M
Encephale; 1994; 20(5):487-93. PubMed ID: 7828511
[TBL] [Abstract][Full Text] [Related]
14. Depression in schizophrenia: a comparison of three measures.
Collins AA; Remington G; Coulter K; Birkett K
Schizophr Res; 1996 May; 20(1-2):205-9. PubMed ID: 8794511
[TBL] [Abstract][Full Text] [Related]
15. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients].
Schneider F; Böser H; Heimann H; Fus I; Friedrich J
Wien Klin Wochenschr; 1992; 104(3):51-5. PubMed ID: 1570706
[TBL] [Abstract][Full Text] [Related]
16. [Depressive symptoms and negative symptoms during schizophrenia].
Dollfus S; Langlois S; Assouly-Besse F; Petit M
Encephale; 1995 Jun; 21 Spec No 3():23-7. PubMed ID: 7628337
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
Bobes J; Arango C; Garcia-Garcia M; Rejas J;
J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic validity of assessment scales for depression in patients with schizophrenia.
Kim SW; Kim SJ; Yoon BH; Kim JM; Shin IS; Hwang MY; Yoon JS
Psychiatry Res; 2006 Sep; 144(1):57-63. PubMed ID: 16904189
[TBL] [Abstract][Full Text] [Related]
19. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
[TBL] [Abstract][Full Text] [Related]
20. Citalopram augmentation of antipsychotic treatment in older schizophrenia patients.
Kasckow JW; Mohamed S; Thallasinos A; Carroll B; Zisook S; Jeste DV
Int J Geriatr Psychiatry; 2001 Dec; 16(12):1163-7. PubMed ID: 11748776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
